154 related articles for article (PubMed ID: 38448141)
21. Molecular Mechanisms of Antifungal Resistance in Mucormycosis.
Ganesan P; Ganapathy D; Sekaran S; Murthykumar K; Sundramoorthy AK; Pitchiah S; Shanmugam R
Biomed Res Int; 2022; 2022():6722245. PubMed ID: 36277891
[TBL] [Abstract][Full Text] [Related]
22. Focusing COVID-19-associated mucormycosis: a major threat to immunocompromised COVID-19.
Sharma N; Wani SN; Behl T; Singh S; Zahoor I; Sehgal A; Bhatia S; Al-Harrasi A; Aleya L; Bungau S
Environ Sci Pollut Res Int; 2023 Jan; 30(4):9164-9183. PubMed ID: 36454526
[TBL] [Abstract][Full Text] [Related]
23. Mucormycosis: risk factors, diagnosis, treatments, and challenges during COVID-19 pandemic.
Sharma A; Goel A
Folia Microbiol (Praha); 2022 Jun; 67(3):363-387. PubMed ID: 35220559
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of EGFR Signaling Protects from Mucormycosis.
Watkins TN; Gebremariam T; Swidergall M; Shetty AC; Graf KT; Alqarihi A; Alkhazraji S; Alsaadi AI; Edwards VL; Filler SG; Ibrahim AS; Bruno VM
mBio; 2018 Aug; 9(4):. PubMed ID: 30108171
[TBL] [Abstract][Full Text] [Related]
25. Mucormycosis: A hidden mystery of fungal infection, possible diagnosis, treatment and development of new therapeutic agents.
Hussain MK; Ahmed S; Khan A; Siddiqui AJ; Khatoon S; Jahan S
Eur J Med Chem; 2023 Jan; 246():115010. PubMed ID: 36566630
[TBL] [Abstract][Full Text] [Related]
26. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
27. COVID-19-Associated Mucormycosis: A Matter of Concern Amid the SARS-CoV-2 Pandemic.
Chandley P; Subba P; Rohatgi S
Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016154
[TBL] [Abstract][Full Text] [Related]
28. [Non-fatal disseminated mucormycosis in a solid organ transplant].
Minet C; Bonadona A; Tabah A; Karkas A; Mescam L; Schwebel C; Hamidfar R; Pison C; Saint-Raymond C; Faure O; Salameire D; Timsit JF
Rev Mal Respir; 2009 Nov; 26(9):998-1002. PubMed ID: 19953048
[TBL] [Abstract][Full Text] [Related]
29. Mucormycosis in Burns: A Review.
Littlehales E; Teague R; Andrew D; Yassaie E
J Burn Care Res; 2022 Mar; 43(2):353-360. PubMed ID: 34874443
[TBL] [Abstract][Full Text] [Related]
30. Gastrointestinal mucormycosis: a success story and appraisal of concepts.
Goel P; Jain V; Sengar M; Mohta A; Das P; Bansal P
J Infect Public Health; 2013 Feb; 6(1):58-61. PubMed ID: 23290094
[TBL] [Abstract][Full Text] [Related]
31. COVID-19 associated mucormycosis - An emerging threat.
Chao CM; Lai CC; Yu WL
J Microbiol Immunol Infect; 2022 Apr; 55(2):183-190. PubMed ID: 35074291
[TBL] [Abstract][Full Text] [Related]
32. Iron Assimilation during Emerging Infections Caused by Opportunistic Fungi with emphasis on Mucorales and the Development of Antifungal Resistance.
Stanford FA; Voigt K
Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33143139
[TBL] [Abstract][Full Text] [Related]
33. Virulence traits and novel drug delivery strategies for mucormycosis post-COVID-19: a comprehensive review.
Faiyazuddin M; Sophia A; Ashique S; Gholap AD; Gowri S; Mohanto S; Karthikeyan C; Nag S; Hussain A; Akhtar MS; Bakht MA; Ahmed MG; Rustagi S; Rodriguez-Morales AJ; Salas-Matta LA; Mohanty A; Bonilla-Aldana DK; Sah R
Front Immunol; 2023; 14():1264502. PubMed ID: 37818370
[TBL] [Abstract][Full Text] [Related]
34. Spotlight on the Mucormycosis Outbreak: A Deadly Fungal Infection That Followed the COVID-19 Pandemic.
Patel SN; Shah S; Panchal J; Desai C; Upadhya IB; Patel M
Cureus; 2023 Feb; 15(2):e35095. PubMed ID: 36938207
[TBL] [Abstract][Full Text] [Related]
35. In Silico Evaluation of Antifungal Compounds from Marine Sponges against COVID-19-Associated Mucormycosis.
Pokharkar O; Lakshmanan H; Zyryanov G; Tsurkan M
Mar Drugs; 2022 Mar; 20(3):. PubMed ID: 35323514
[TBL] [Abstract][Full Text] [Related]
36. Disseminated infection due to Saksenaea vasiformis secondary to cutaneous mucormycosis.
Gómez-Camarasa C; Rojo-Martín MD; Miranda-Casas C; Alastruey-Izquierdo A; Aliaga-Martínez L; Labrador-Molina JM; Navarro-Marí JM
Mycopathologia; 2014 Feb; 177(1-2):97-101. PubMed ID: 24178374
[TBL] [Abstract][Full Text] [Related]
37. Fatal cutaneous mucormycosis after kidney transplant.
Davuodi S; Manshadi SA; Salehi MR; Yazdi F; Khazravi M; Fazli JT
Exp Clin Transplant; 2015 Feb; 13(1):82-5. PubMed ID: 25376012
[TBL] [Abstract][Full Text] [Related]
38. Host-iron assimilation: pathogenesis and novel therapies of mucormycosis.
Ibrahim AS
Mycoses; 2014 Dec; 57 Suppl 3(0 3):13-7. PubMed ID: 25178879
[TBL] [Abstract][Full Text] [Related]
39. Managing mucormycosis in a resource-limited setting: challenges and possible solutions.
Gupta N; Singh G; Xess I; Soneja M
Trop Doct; 2019 Apr; 49(2):153-155. PubMed ID: 30691355
[TBL] [Abstract][Full Text] [Related]
40. Genomic analysis of the basal lineage fungus Rhizopus oryzae reveals a whole-genome duplication.
Ma LJ; Ibrahim AS; Skory C; Grabherr MG; Burger G; Butler M; Elias M; Idnurm A; Lang BF; Sone T; Abe A; Calvo SE; Corrochano LM; Engels R; Fu J; Hansberg W; Kim JM; Kodira CD; Koehrsen MJ; Liu B; Miranda-Saavedra D; O'Leary S; Ortiz-Castellanos L; Poulter R; Rodriguez-Romero J; Ruiz-Herrera J; Shen YQ; Zeng Q; Galagan J; Birren BW; Cuomo CA; Wickes BL
PLoS Genet; 2009 Jul; 5(7):e1000549. PubMed ID: 19578406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
